Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dehydropeptidase I (DHP-I), also known as membrane dipeptidase or DPEP1, is a zinc-dependent enzyme predominantly found in the kidneys. It plays a crucial role in the metabolism and hydrolysis of various dipeptides and certain antibiotics, most notably carbapenems such as imipenem. Inhibition of DHP-I by cilastatin is essential for maintaining the therapeutic efficacy of imipenem.
Cilastatin inhibits dehydropeptidase I, preventing the renal metabolism of imipenem and increasing its systemic half-life and bioavailability.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dehydropeptidase I (DHP-I).